Stock Events

Argent Biopharma (RGTLF) Q1 2024 Earnings

28FebConfirmed
Q1 2024
-20.86
-20.53
-20.19
-19.86

Details

Expected EPS
N/A
Actual EPS
-20.8590992
Surprise EPS
-20.86
Surprise Percent
+∞%

Description

Argent Biopharma (RGTLF) has reported earnings of -20.8590992 per share for Q1 2024.

0 Comments

Share your thoughts